Dr. Ralph Hauke, MD
Claim this profileNebraska Cancer Specialists
Expert in Cancer
Studies Prostate Cancer
35 reported clinical trials
73 drugs studied
About Ralph Hauke, MD
Education:
- Obtained MD (Doctor of Medicine) from the University of Nebraska Medical Center in 1986.
- Completed Residency in Internal Medicine at the University of Nebraska Medical Center in 1989.
- Finished Fellowship in Hematology/Oncology at the University of Nebraska Medical Center in 1991.
Experience:
- Currently practices as an oncologist and hematologist at Nebraska Cancer Specialists.
- Extensive training and medical education at the University of Nebraska Medical Center.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Prostate Cancer
Stage IV
BRCA positive
synaptophysin positive
Affiliated Hospitals
Clinical Trials Ralph Hauke, MD is currently running
Immunotherapy
for Prostate Cancer
This is a multi-centre, Phase 1/2, open-label clinical trial of the VTP-850 prime-boost immunotherapeutic in men with biochemical recurrence after definitive local therapy for prostate cancer.
Recruiting1 award Phase 1 & 2
Lorigerlimab + Docetaxel
for Prostate Cancer
This trial is testing whether adding lorigerlimab to standard treatments (docetaxel and prednisone) can slow down prostate cancer that has spread and is not responding to hormone therapy. Lorigerlimab helps the immune system fight cancer, while docetaxel kills cancer cells, and prednisone manages side effects. About 150 patients will participate, with some receiving the new combination and others receiving just the standard treatment.
Recruiting1 award Phase 2
More about Ralph Hauke, MD
Clinical Trial Related5 years of experience running clinical trials · Led 35 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Ralph Hauke, MD has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Docetaxel
- Cisplatin
- Prednisone
Breakdown of trials Ralph Hauke, MD has run
Cancer
Prostate Cancer
Melanoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ralph Hauke, MD specialize in?
Ralph Hauke, MD focuses on Cancer and Prostate Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ralph Hauke, MD currently recruiting for clinical trials?
Yes, Ralph Hauke, MD is currently recruiting for 13 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Ralph Hauke, MD has studied deeply?
Yes, Ralph Hauke, MD has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Ralph Hauke, MD?
Apply for one of the trials that Ralph Hauke, MD is conducting.
What is the office address of Ralph Hauke, MD?
The office of Ralph Hauke, MD is located at: Nebraska Cancer Specialists, Omaha, Nebraska 68114 United States. This is the address for their practice at the Nebraska Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.